Liang, Lilian Yan
Wong, Vincent Wai-Sun
Toyoda, Hidenori
Tse, Yee-Kit
Yip, Terry Cheuk-Fung
Yuen, Becky Wing-Yan
Tada, Toshifumi
Kumada, Takashi
Lee, Hye-Won
Lui, Grace Chung-Yan
Chan, Henry Lik-Yuen
Wong, Grace Lai-Hung http://orcid.org/0000-0002-2863-9389
Funding for this research was provided by:
Health and Medical Research Fund (15160551)
Article History
Received: 27 April 2020
Accepted: 8 June 2020
First Online: 17 June 2020
Compliance with ethical standards
:
: Vincent Wong has served as an advisory committee member for 3 V-BIO, AbbVie, Allergan, Boehringer Ingelheim, Echosens, Gilead Sciences, Intercept, Janssen, Novartis, Novo Nordisk, Perspectum Diagnostics, Pfizer, TARGET-NASH and Terns; and a speaker for Bristol-Myers Squibb, Echosens, Gilead Sciences and Merck. He has also received a research grant from Gilead Sciences. Hidenori Toyoda has served as a speaker for AbbVie and Merck. Terry Yip has served as a speaker for Gilead Sciences. Takashi Kumada has served as a speaker for Abbvie, Eisai and Gilead Sciences. Henry Chan is an advisor for AbbVie, Aptorum, Altimmune, Arbutus, Intellia, Janssen, Gilead, GRAIL, Medimmune, Roche, Vir Biotechnology; and a speaker for AbbVie, Gilead and Roche. Grace Lui has served as an advisory committee member for Gilead, speaker for Merck and Gilead, and received research grant from Gilead. Grace Wong has served as an advisory committee member for Gilead Sciences, as a speaker for Abbott, Abbvie, Bristol-Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen and Roche, and received research grant from Gilead Sciences. The other authors declare that they have no conflict of interest (potential personal and financial interests inclusive).